Stock Information
Immunome Inc (IMNM)
Ticker Symbol: IMNM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,002.95 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.4127
Revenue (TTM): $0.07 M
Dividend Yield: N/A%
ROE: -57.61%
Latest News
-
Immunome Submits New Drug Application To FDA For Varegacestat To Treat Desmoid Tumors, Backed By Phase 3 RINGSIDE Trial Showing 84% Reduction In Disease Progression Risk
Wed, Apr 29, 2026 7:33 AM
-
Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors
Wed, Apr 29, 2026 7:31 AM
Key Financials
Financial data not available
